Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy J Racine

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Protocols|October 13, 2025
Humanized Mouse Models for Type 1 DiabetesDavid V Serreze, Marissa Tousey-Pfarrer, Jeremy J Racine
Cold Spring Harbor Perspectives in Medicine|June 17, 2024
Advancing Animal Models of Human Type 1 DiabetesDavid V Serreze, Jennifer R Dwyer, Jeremy J Racine
Diabetes|January 25, 2014
Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD miceJeremy J Racine, Miao Wang, Mingfeng Zhang, et al.
Frontiers in Immunology|November 17, 2022
Editorial: Genetic basis of tolerance induction defects underlying the development of autoimmune pathologiesJeremy J Racine, Laurence Morel, Yi-Guang Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 28, 2014
MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic miceJeremy J Racine, Mingfeng Zhang, Miao Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 11, 2018
HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin ExpressionJennifer Schloss, Riyasat Ali, Jeremy J Racine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protectionJeremy J Racine, Jennifer R Dwyer, Harold D Chapman, et al.
Diabetes|March 20, 2026
Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid- Overexpressing NOD MiceJennifer R Dwyer, Jeremy J Racine, Harold D Chapman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2014
Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effectsHeather F Johnston, Yajing Xu, Jeremy J Racine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2017
Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 CotherapyQiming Wang, Jeremy J Racine, Jeremy J Ratiu, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Protocols|October 13, 2025
Humanized Mouse Models for Type 1 DiabetesDavid V Serreze, Marissa Tousey-Pfarrer, Jeremy J Racine
Cold Spring Harbor Perspectives in Medicine|June 17, 2024
Advancing Animal Models of Human Type 1 DiabetesDavid V Serreze, Jennifer R Dwyer, Jeremy J Racine
Diabetes|January 25, 2014
Induction of mixed chimerism depletes pre-existing and de novo-developed autoreactive B cells in autoimmune NOD miceJeremy J Racine, Miao Wang, Mingfeng Zhang, et al.
Frontiers in Immunology|November 17, 2022
Editorial: Genetic basis of tolerance induction defects underlying the development of autoimmune pathologiesJeremy J Racine, Laurence Morel, Yi-Guang Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 28, 2014
MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic miceJeremy J Racine, Mingfeng Zhang, Miao Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 11, 2018
HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin ExpressionJennifer Schloss, Riyasat Ali, Jeremy J Racine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 12, 2025
Direct-in-NOD genetic ablation of Bcl3 leads to complete type 1 diabetes protectionJeremy J Racine, Jennifer R Dwyer, Harold D Chapman, et al.
Diabetes|March 20, 2026
Multiple Mechanisms Contribute to Robust Type 1 Diabetes Protection in Nfkbid- Overexpressing NOD MiceJennifer R Dwyer, Jeremy J Racine, Harold D Chapman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 7, 2014
Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effectsHeather F Johnston, Yajing Xu, Jeremy J Racine, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2017
Transient BAFF Blockade Inhibits Type 1 Diabetes Development in Nonobese Diabetic Mice by Enriching Immunoregulatory B Lymphocytes Sensitive to Deletion by Anti-CD20 CotherapyQiming Wang, Jeremy J Racine, Jeremy J Ratiu, et al.
Pageof 3